Germline Mutation in BRCA1 or BRCA2 and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer

Francisco J Candido-dos-Reis; Honglin Song; Ellen L Goode; Julie M Cunningham; Brooke L Fridley; Melissa C Larson; Kathryn Alsop; Ed Dicks; Patricia Harrington; Susan J Ramus; Anna de Fazio; Gillian Mitchell; Sian Fereday; Kelly L Bolton; Charlie Gourley; Caroline Michie; Beth Karlan; Jenny Lester; Christine Walsh; Ilana Cass; Hakan Olsson; Martin Gore; Javier J Benitez; Maria J Garcia; Irene Andrulis; Anna Marie Mulligan; Gord Glendon; Ignacio Blanco; Conxi Lazaro; Alice S Whittemore; Valerie McGuire; Weiva Sieh; Marco Montagna; Elisa Alducci; Siegal Sadetzki; Angela Chetrit; Ava Kwong; Susanne K Kjaer; Allan Jensen; Estrid Hogdall; Susan Neuhausen; Robert Nussbaum; Mary Daly; Mark H Greene; Phuong L Mai; Jennifer T Loud; Kirsten Moysich; Amanda E Toland; Diether Lambrechts; Steve Ellis; Debra Frost; James D Brenton; Marc Tischkowitz; Douglas F Easton; Antonis Antoniou; Georgia Chenevix-Trench; Simon A Gayther; David Bowtell; Paul DP Pharoah

Journal article

Germline Mutation in BRCA1 or BRCA2 and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer

Francisco J Candido-dos-Reis, Honglin Song, Ellen L Goode, Julie M Cunningham, Brooke L Fridley, Melissa C Larson, Kathryn Alsop, Ed Dicks, Patricia Harrington, Susan J Ramus, Anna de Fazio, Gillian Mitchell, Sian Fereday, Kelly L Bolton, Charlie Gourley, Caroline Michie, Beth Karlan, Jenny Lester, Christine Walsh, Ilana Cass Show all

CLINICAL CANCER RESEARCH | AMER ASSOC CANCER RESEARCH | Published : 2015

DOI: 10.1158/1078-0432.CCR-14-2497

University of Melbourne Researchers

Gillian Mitchell Author The Sir Peter MacCallum Department of Oncology

David Bowtell Author The Sir Peter MacCallum Department of Oncology

Related Projects (2)

AUSTRALIAN OVARIAN CANCER STUDY (AOCS): A MULTIDISCIPLINARY OVARIAN CANCER RESOURCE FOR THE GENOMICS ERA

Ovarian cancer is relatively uncommon and is histologically very diverse, making it difficult to analyse ovarian cancer at a molecular level..

Molecular Epidemiology of Ovarian Cancer: The Australian Ovarian Cancer Study National Clinical Follow-Up Core

Ovarian cancer is the seventh most common cancer in Australian women and fifth most common cause of cancer death, with approximately 1200 ne..

Grants

Awarded by American Cancer Society Early Detection Professorship

Awarded by Cancer Australia

Awarded by Cancer Research UK

Awarded by Catalan Health Institute and Autonomous Government of Catalonia

Awarded by European Research Council

Awarded by National Cancer Institute

Awarded by National Health and Medical Research Council of Australia

Awarded by Ovarian Cancer Research Program of the US Department of Defense

Awarded by U.S. Army Medical Research and Materiel Command

Awarded by Chief Scientist Office

Awarded by National Breast Cancer Foundation

Awarded by The Francis Crick Institute

Awarded by NATIONAL CANCER INSTITUTE

Funding Acknowledgements

F.J. Candido-dos-Reis was funded by the Sao Paulo Research Foundation (FAPESP). The contributing studies were funded by grants from The American Cancer Society Early Detection Professorship (SIOP-06-258-01-COUN); Asociacion Espanola Contra el Cancer; Cancer Australia (509303); the Cancer Council Victoria; the Cancer Council Queensland, the Cancer Council New South Wales; Cancer Research UK (C490/A10119, C490/A10124, C490/A16561); Carlos III Health Institute; Catalan Health Institute and Autonomous Government of Catalonia. (ISCIIIRETIC RD06/0020/105, PI10/01422, PI10/31488, 2009SGR290); the European Research Council (310018, 2011294576); the Mermaid Project (Mermaid 1); Ministero della Salute of Italy "5 x 1000" fund; the National Breast Cancer Foundation of Australia; National Cancer Institute (UM1CA164920, R01CA178535, R01CA61107, U01CA71966, R01CA16056, K07CA143047, and U01CA69417, P50CA136393, R01CA122443); the NIHR Biomedical Research Centres at the University of Cambridge and the Royal Marsden NHS Foundation Trust and Institute of Cancer Research; the National Health and Medical Research Council of Australia (400281, 400413); Ovarian Cancer Research Program of the US Department of Defense (W81XWH-08-1-0684 and W81XWH-08-10685); the Peter MacCallum Cancer Centre Foundation; Scottish Funding Council; the Seventh Framework Programme of the European Union (FP/2007-2013); Swedish Cancer Society; Spanish Health Research Fund; Swedish Research Council; the University of Sydney Cancer Research Fund; and U.S. Army Medical Research and Materiel Command (DAMD17-01-1-0729).